In the news: Patents and their role in the pharma industry
With pharma’s portfolio shifting substantially toward new product types and personalised treatments, process technology needs to overcome multiple challenges across the supply chain. Competition is fierce and the need for new and revolutionary solutions for drug development starts as early as the selection of the optimal route of synthesis and starting material, often calling for ‘out-of-the-box’ thinking.
Breakthrough solutions, as small as they may be, can drive your business forward. Nevertheless, if you have not considered the intellectual property (IP) landscape, then, you have only developed half a solution, which can drive your business right into the ground.
Read the full article here.